Caspase‐6 is a key regulator of cross‐talk signal way in PANoptosis in cancer
Immunology · 2023
DOI: 10.1111/imm.13633 ↗At a glance
Übersichtsarbeit in Immunology, 2023. Written by Ling Qi and 5 co-authors. Institution: Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China. Major MEDLINE topics: Apoptosis, Neoplasms. Cited 41 times so far (Crossref); 114 references. Funded by: Wu Jieping Medical Foundation.
Abstract (original language)
Cysteinyl aspartate specific proteinase (caspase)‐6 belongs to the caspase family and plays a vital role in mediating cell death. Under certain conditions, three pathways of programmed cell death (PCD), including apoptosis, necroptosis and pyroptosis (PANoptosis), transform one way into another, with enormous therapeutic potential. Initially, scholars reported that caspase‐6 is a caspase executor that mediates apoptosis. With the ceaseless exploration of the PCD types, studies have demonstrated that caspase‐6 mediates pyroptosis by regulating gasdermin D and mediates necroptosis by regulating mixed lineage kinase domain‐like. By regulating PANoptosis, caspase‐6 plays a crucial role in tumorigenesis in humans and mediates anti‐tumour immunity. Therefore, a comprehensive understanding of caspase‐6 function in cancer via PANoptosis is important for the prevention and therapy of tumours. This article summarized the function of caspase‐6 in PANoptosis and its impact on cancer development, providing targets and strategies for tumour treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
- Department of Medical Oncology, the Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei, China.
- Department of Medical Oncology, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
ORCID profiles: Yanjing Li
Funding
- Wu Jieping Medical Foundation
Cite
APA
Qi, L., Wang, L., Jin, M., Jiang, M., Li, L., & Li, Y. (2023). Caspase‐6 is a key regulator of cross‐talk signal way in PANoptosis in cancer. Immunology. https://doi.org/10.1111/imm.13633
Vancouver
Qi L, Wang L, Jin M, Jiang M, Li L, Li Y. Caspase‐6 is a key regulator of cross‐talk signal way in PANoptosis in cancer. Immunology. 2023. doi:10.1111/imm.13633
BibTeX
@article{Qi2023,
author = {Qi, Ling and Wang, Li and Jin, Mengru and Jiang, Mingxia and Li, Lisha and Li, Yanjing},
title = {Caspase‐6 is a key regulator of cross‐talk signal way in PANoptosis in cancer},
journal = {Immunology},
year = {2023},
doi = {10.1111/imm.13633}
}
EUVIMED